A citation-based method for searching scientific literature

Jieru E Lin, Michael Valentino, Glen Marszalowicz, Michael S Magee, Peng Li, Adam E Snook, Brian A Stoecker, Chang Chang, Scott A Waldman. Toxins (Basel) 2010
Times Cited: 25







List of co-cited articles
181 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
Jeffrey M Johnston, Caroline B Kurtz, James E Macdougall, Bernard J Lavins, Mark G Currie, Donald A Fitch, Chris O'Dea, Mollie Baird, Anthony J Lembo. Gastroenterology 2010
166
40

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Viola Andresen, Michael Camilleri, Irene A Busciglio, April Grudell, Duane Burton, Sanna McKinzie, Amy Foxx-Orenstein, Caroline B Kurtz, Vineeta Sharma, Jeffrey M Johnston,[...]. Gastroenterology 2007
177
36

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
Robert W Busby, Alexander P Bryant, Wilmin P Bartolini, Etchell A Cordero, Gerhard Hannig, Marco M Kessler, Shalina Mahajan-Miklos, Christine M Pierce, Robert M Solinga, Li Jing Sun,[...]. Eur J Pharmacol 2010
152
32

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
H Eutamene, S Bradesi, M Larauche, V Theodorou, C Beaufrand, G Ohning, J Fioramonti, M Cohen, A P Bryant, C Kurtz,[...]. Neurogastroenterol Motil 2010
139
32

Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
Joel Castro, Andrea M Harrington, Patrick A Hughes, Christopher M Martin, Pei Ge, Courtney M Shea, Hong Jin, Sarah Jacobson, Gerhard Hannig, Elizabeth Mann,[...]. Gastroenterology 2013
179
32

Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
907
28

Functional bowel disorders.
George F Longstreth, W Grant Thompson, William D Chey, Lesley A Houghton, Fermin Mearin, Robin C Spiller. Gastroenterology 2006
28

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
105
24

Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
F K Hamra, L R Forte, S L Eber, N V Pidhorodeckyj, W J Krause, R H Freeman, D T Chin, J A Tompkins, K F Fok, C E Smith. Proc Natl Acad Sci U S A 1993
301
24

Guanylate cyclase-C receptor activation: unexpected biology.
Stuart M Brierley. Curr Opin Pharmacol 2012
45
24

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
William D Chey, Anthony J Lembo, Bernard J Lavins, Steven J Shiff, Caroline B Kurtz, Mark G Currie, James E MacDougall, Xinwei D Jia, James Z Shao, Donald A Fitch,[...]. Am J Gastroenterol 2012
292
24

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Satish Rao, Anthony J Lembo, Steven J Shiff, Bernard J Lavins, Mark G Currie, Xinwei D Jia, Kelvin Shi, James E MacDougall, James Z Shao, Paul Eng,[...]. Am J Gastroenterol 2012
258
24

Two randomized trials of linaclotide for chronic constipation.
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, Caroline B Kurtz, James E MacDougall, Xinwei D Jia, James Z Shao, Bernard J Lavins, Mark G Currie, Donald A Fitch,[...]. N Engl J Med 2011
229
20

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.
Alexander P Bryant, Robert W Busby, Wilmin P Bartolini, Etchell A Cordero, Gerhard Hannig, Marco M Kessler, Christine M Pierce, Robert M Solinga, Jenny V Tobin, Shalina Mahajan-Miklos,[...]. Life Sci 2010
124
20

Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.
Kunwar Shailubhai, Stephen Comiskey, John A Foss, Rong Feng, Laura Barrow, Gail M Comer, Gary S Jacob. Dig Dis Sci 2013
67
20

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
Robert W Busby, Marco M Kessler, Wilmin P Bartolini, Alexander P Bryant, Gerhard Hannig, Carolyn S Higgins, Robert M Solinga, Jenny V Tobin, James D Wakefield, Caroline B Kurtz,[...]. J Pharmacol Exp Ther 2013
90
20


Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
E M M Quigley, J Tack, W D Chey, S S Rao, J Fortea, M Falques, C Diaz, S J Shiff, M G Currie, J M Johnston. Aliment Pharmacol Ther 2013
97
16

A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.
William D Chey, Michael Camilleri, Lin Chang, Leif Rikner, Hans Graffner. Am J Gastroenterol 2011
128
16


Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Inmaculada Silos-Santiago, Gerhard Hannig, Helene Eutamene, Elena E Ustinova, Sylvie G Bernier, Pei Ge, Christopher Graul, Sarah Jacobson, Hong Jin, Elaine Liong,[...]. Pain 2013
53
16

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
86
12

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
85
12

Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Stephen L Carrithers, Cobern E Ott, Michael J Hill, Brett R Johnson, Weiyan Cai, Jason J Chang, Rajesh G Shah, Congmei Sun, Elizabeth A Mann, Manasses C Fonteles,[...]. Kidney Int 2004
73
12

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
106
12

Guanylyl cyclase is a heat-stable enterotoxin receptor.
S Schulz, C K Green, P S Yuen, D L Garbers. Cell 1990
530
12

Opossum colonic mucosa contains uroguanylin and guanylin peptides.
F K Hamra, W J Krause, S L Eber, R H Freeman, C E Smith, M G Currie, L R Forte. Am J Physiol 1996
41
12

Characterization of human uroguanylin: a member of the guanylin peptide family.
T Kita, C E Smith, K F Fok, K L Duffin, W M Moore, P J Karabatsos, J F Kachur, F K Hamra, N V Pidhorodeckyj, L R Forte. Am J Physiol 1994
118
12


Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
98
12

Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
F K Hamra, S L Eber, D T Chin, M G Currie, L R Forte. Proc Natl Acad Sci U S A 1997
98
12



Transmembrane guanylate cyclase in intestinal pathophysiology.
Kris A Steinbrecher, Mitchell B Cohen. Curr Opin Gastroenterol 2011
15
20

Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior.
Rong Gong, Cheng Ding, Ji Hu, Yao Lu, Fei Liu, Elizabeth Mann, Fuqiang Xu, Mitchell B Cohen, Minmin Luo. Science 2011
76
12

Familial diarrhea syndrome caused by an activating GUCY2C mutation.
Torunn Fiskerstrand, Najla Arshad, Bjørn Ivar Haukanes, Rune Rose Tronstad, Khanh Do-Cong Pham, Stefan Johansson, Bjarte Håvik, Siv L Tønder, Shawn E Levy, Damien Brackman,[...]. N Engl J Med 2012
128
12

E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.
Ralph A Giannella, Elizabeth A Mann. Trans Am Clin Climatol Assoc 2003
26
12

Linaclotide - a secretagogue and antihyperalgesic agent - what next?
A E Bharucha, D R Linden. Neurogastroenterol Motil 2010
19
15

Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C.
Philipp R Weiglmeier, Paul Rösch, Hanna Berkner. Toxins (Basel) 2010
34
12


Linaclotide: first global approval.
Vanessa McWilliams, Glenn Whiteside, Kate McKeage. Drugs 2012
16
18


Prucalopride: safety, efficacy and potential applications.
Eamonn M M Quigley. Therap Adv Gastroenterol 2012
48
12

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
Rebecca M Lovell, Alexander C Ford. Clin Gastroenterol Hepatol 2012
12

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
J Tack, M Camilleri, L Chang, W D Chey, J J Galligan, B E Lacy, S Müller-Lissner, E M M Quigley, J Schuurkes, J H De Maeyer,[...]. Aliment Pharmacol Ther 2012
195
12




Elobixibat for the treatment of constipation.
Banny S Wong, Michael Camilleri. Expert Opin Investig Drugs 2013
29
12

Isolation, sequencing, and structure-activity relationships of cyclotides.
David C Ireland, Richard J Clark, Norelle L Daly, David J Craik. J Nat Prod 2010
47
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.